Document 0619
 DOCN  M9650619
 TI    Seroprevalence of anti-HCV among HIV-infected persons and general
       population.
 DT    9605
 AU    Suwanagool S; Tieangrim S; Ratanasuwan W; Mekanantagosol S;
       Luengrojanakul P; Kunasol P; Department of Preventive and Social
       Medicine, Faculty of; Medicine, Siriraj Hospital, Mahidol University,
       Bangkok,; Thailand.
 SO    J Med Assoc Thai. 1995 Nov;78(11):611-7. Unique Identifier : AIDSLINE
       MED/96108090
 AB    From November 1993 to December 1994, the seroprevalence of anti-HCV,
       HBsAg was studied among 346 HIV-infected persons (asymptomatic
       HIV-infected persons and AIDS patients) and 1,023 subjects from the
       general population (including 119 cord blood samples). The prevalence of
       anti-HCV, HBsAg among HIV-infected patients aged 15-45+ years was 11.0
       and 11.6 per cent respectively which is significantly higher than the
       comparable levels for the general population (1.9% and 4.7%) in the age
       group 15-44 years. There was no statistically significant association of
       anti-HCV and HBsAg prevalence among 200 asymptomatic HIV-infected
       carriers and 146 AIDS patients. Assays for anti-HCV among blood donors
       are highly recommended to reduce the development of liver disease or
       cirrhosis in the immediate future.
 DE    Adolescence  Adult  Age Distribution  Aged  Chi-Square Distribution
       Enzyme-Linked Immunosorbent Assay  Female  Hepatitis B Surface
       Antigens/ANALYSIS  Hepatitis C/*COMPLICATIONS/*EPIDEMIOLOGY/IMMUNOLOGY
       Hepatitis C Antibodies/*ANALYSIS  Human  HIV
       Infections/*COMPLICATIONS/IMMUNOLOGY  Male  Middle Age  Prevalence  Risk
       Factors  Seroepidemiologic Methods  Sex Distribution  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).